tradingkey.logo

Natera Inc

NTRA
228.400USD
-3.550-1.53%
Close 12/15, 16:00ETQuotes delayed by 15 min
31.41BMarket Cap
LossP/E TTM

Natera Inc

228.400
-3.550-1.53%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Natera Inc

Currency: USD Updated: 2025-12-15

Key Insights

Natera Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 5/78 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 235.25.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Natera Inc's Score

Industry at a Glance

Industry Ranking
5 / 78
Overall Ranking
44 / 4589
Industry
Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 21 analysts
Buy
Current Rating
235.254
Target Price
-1.62%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Natera Inc Highlights

StrengthsRisks
Natera, Inc. provides cell-free DNA (cfDNA) and genetic testing, dedicated to oncology, women’s health, and organ health. The Company's cfDNA technology platform combines novel molecular biology techniques with bioinformatics software and artificial intelligence. It has leveraged its platform to develop non-invasive prenatal test on the market (Panorama), the first tumor-specific assay for truly individualized cancer care (Signatera), best-in-class rejection assessment for kidney transplantation (Prospera) and others. In the women’s health space, it develops and commercializes non- or minimally- invasive tests to evaluate risk for, and thereby enable early detection of, a range of genetic conditions, such as Down syndrome. In oncology, it is focused on detecting molecular residual disease and recurrence monitoring in solid tumors, among others. In organ health, it offers tests to assess kidney, heart, and lung transplant rejection as well as genetic testing for chronic kidney disease.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 106.88% year-on-year.
Undervalued
The company’s latest PE is -99.88, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 128.93M shares, decreasing 2.13% quarter-over-quarter.
Held by Steven Cohen
Star Investor Steven Cohen holds 238.96K shares of this stock.

Financial Health

Currency: USD Updated: 2025-12-15

The current financial score of Natera Inc is 8.16, ranking 31/78 in the Healthcare Providers & Services industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 592.18M, representing a year-over-year increase of 34.66%, while its net profit experienced a year-over-year increase of 177.11%.

Score

Industry at a Glance

Previous score
8.16
Change
0

Financials

10.00

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

6.06

Operational Efficiency

8.74

Growth Potential

8.64

Shareholder Returns

7.35

Natera Inc's Company Valuation

Currency: USD Updated: 2025-12-15

The current valuation score of Natera Inc is 7.33, ranking 35/78 in the Healthcare Providers & Services industry. Its current P/E ratio is -99.88, which is -93.42% below the recent high of -6.57 and -17.53% above the recent low of -117.39.

Score

Industry at a Glance

Previous score
7.33
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 5/78
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2025-12-15

The current earnings forecast score of Natera Inc is 8.48, ranking 11/78 in the Healthcare Providers & Services industry. The average price target for Natera Inc is 239.00, with a high of 280.00 and a low of 186.00.

Score

Industry at a Glance

Previous score
8.48
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 21 analysts
Buy
Current Rating
235.254
Target Price
-1.62%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

65
Total
7
Median
9
Average
Company name
Ratings
Analysts
Natera Inc
NTRA
21
CVS Health Corp
CVS
29
HCA Healthcare Inc
HCA
27
Teladoc Health Inc
TDOC
27
Tenet Healthcare Corp
THC
24
Universal Health Services Inc
UHS
22
1
2
3
...
13

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-12-15

The current price momentum score of Natera Inc is 9.06, ranking 22/78 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 249.20 and the support level at 205.30, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
9.32
Change
-0.26

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(2)
Neutral(3)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-5.086
Neutral
RSI(14)
54.914
Neutral
STOCH(KDJ)(9,3,3)
19.541
Neutral
ATR(14)
6.282
Low Volatility
CCI(14)
-155.108
Sell
Williams %R
86.773
Oversold
TRIX(12,20)
0.656
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(3)
Neutral(0)
Buy(3)
Indicators
Value
Direction
MA5
232.012
Sell
MA10
236.066
Sell
MA20
232.007
Sell
MA50
206.406
Buy
MA100
183.496
Buy
MA200
168.293
Buy

Institutional Confidence

Currency: USD Updated: 2025-12-15

The current institutional shareholding score of Natera Inc is 10.00, ranking 1/78 in the Healthcare Providers & Services industry. The latest institutional shareholding proportion is 93.94%, representing a quarter-over-quarter decrease of 2.79%. The largest institutional shareholder is The Vanguard, holding a total of 12.33M shares, representing 8.86% of shares outstanding, with 1.95% decrease in holdings.

Score

Industry at a Glance

Previous score
10.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
The Vanguard Group, Inc.
Star Investors
12.62M
+2.27%
T. Rowe Price Associates, Inc.
Star Investors
12.07M
+15.72%
JP Morgan Asset Management
8.92M
+39.53%
BlackRock Institutional Trust Company, N.A.
6.78M
+1.51%
Farallon Capital Management, L.L.C.
4.82M
+6.02%
State Street Investment Management (US)
3.32M
-1.57%
Duquesne Family Office LLC
Star Investors
3.09M
-9.32%
Geode Capital Management, L.L.C.
2.55M
+6.99%
Franklin Advisers, Inc.
1.93M
+20.65%
Wellington Management Company, LLP
2.63M
-13.92%
1
2

Risk Assessment

Currency: USD Updated: 2025-12-15

The current risk assessment score of Natera Inc is 8.13, ranking 12/78 in the Healthcare Providers & Services industry. The company's beta value is 1.62. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.

Score

Industry at a Glance

Previous score
8.13
Change
0
Beta vs S&P 500 index
1.62
VaR
+5.11%
240-Day Maximum Drawdown
+25.29%
240-Day Volatility
+49.14%

Return

Best Daily Return
60 days
+4.46%
120 days
+7.70%
5 years
+19.13%
Worst Daily Return
60 days
-5.16%
120 days
-5.27%
5 years
-32.79%
Sharpe Ratio
60 days
+3.24
120 days
+1.82
5 years
+0.58

Risk Assessment

Maximum Drawdown
240 days
+25.29%
3 years
+39.94%
5 years
+77.74%
Return-to-Drawdown Ratio
240 days
+1.74
3 years
+3.50
5 years
+0.37
Skewness
240 days
+0.52
3 years
+1.16
5 years
-0.19

Volatility

Realised Volatility
240 days
+49.14%
5 years
+60.57%
Standardised True Range
240 days
+2.97%
5 years
+1.89%
Downside Risk-Adjusted Return
120 days
+292.65%
240 days
+292.65%
Maximum Daily Upside Volatility
60 days
+26.82%
Maximum Daily Downside Volatility
60 days
+23.86%

Liquidity

Average Turnover Rate
60 days
+0.99%
120 days
+1.04%
5 years
--
Turnover Deviation
20 days
+0.91%
60 days
-9.46%
120 days
-4.91%

Peer Comparison

Healthcare Providers & Services
Natera Inc
Natera Inc
NTRA
8.46 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Alignment Healthcare Inc
Alignment Healthcare Inc
ALHC
8.86 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lifestance Health Group Inc
Lifestance Health Group Inc
LFST
8.56 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cigna Group
Cigna Group
CI
8.51 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Option Care Health Inc
Option Care Health Inc
OPCH
8.48 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Addus Homecare Corp
Addus Homecare Corp
ADUS
8.40 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more

FAQs

How does TradingKey generate the Stock Score of Natera Inc?

The TradingKey Stock Score provides a comprehensive assessment of Natera Inc based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Natera Inc’s performance and outlook.

How do we generate the financial health score of Natera Inc?

To generate the financial health score of Natera Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects Natera Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Natera Inc.

How do we generate the company valuation score of Natera Inc?

To generate the company valuation score of Natera Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Natera Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Natera Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Natera Inc.

How do we generate the earnings forecast score of Natera Inc?

To calculate the earnings forecast score of Natera Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Natera Inc’s future.

How do we generate the price momentum score of Natera Inc?

When generating the price momentum score for Natera Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of Natera Inc’s prices. A higher score indicates a more stable short-term price trend for Natera Inc.

How do we generate the institutional confidence score of Natera Inc?

To generate the institutional confidence score of Natera Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Natera Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Natera Inc.

How do we generate the risk management score of Natera Inc?

To assess the risk management score of Natera Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of Natera Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Natera Inc.
KeyAI